Hallström C, Crouch G, Robson M, Shine P
Department of Psychiatry, Charing Cross Hospital, London, UK.
Postgrad Med J. 1988;64 Suppl 2:40-4.
Forty four subjects were treated for benzodiazepine dependence. The withdrawal programme lasted for 10 weeks and included regular group support sessions. Patients were also treated with either propranolol, placebo or "no pill" under double blind conditions. Twenty three patients complied with the full treatment regimen and completed the trial. The outcome of treatment was moderately successful, with 8 out of the 23 patients stopping their tranquilizers and a further 11 achieving a reduction of 50% or more of their original benzodiazepine dose. Tranquilizer dependence is a difficult condition to treat, but preliminary results suggest that propranolol is helpful in reducing the symptoms of benzodiazepine withdrawal.
44名受试者接受了苯二氮䓬类药物依赖治疗。戒断计划持续10周,包括定期的小组支持会议。在双盲条件下,患者还接受了普萘洛尔、安慰剂或“无药丸”治疗。23名患者遵守了完整的治疗方案并完成了试验。治疗结果取得了一定成功,23名患者中有8名停止服用镇静剂,另有11名患者将其原来的苯二氮䓬类药物剂量减少了50%或更多。镇静剂依赖是一种难以治疗的疾病,但初步结果表明普萘洛尔有助于减轻苯二氮䓬类药物戒断症状。